Tyra Biosciences, Inc. Operating Lease, Liability, Current
Tyra Biosciences, Inc. (TYRA) had Operating Lease, Liability, Current of $504.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability, Current $504.00K.
- 2026-03-31: Operating Lease, Liability, Current $488.00K.
- 2025-12-31: Operating Lease, Liability, Current $472.00K.
- 2025-09-30: Operating Lease, Liability, Current $456.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $504.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $488.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $472.00K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $456.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $441.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $426.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $412.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $398.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $383.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $370.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $280.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $148.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $144.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $144.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $140.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $127.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $123.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $119.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $202.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $135.00K 10-Q · filed 2021-11-03 | |
| 2020-12-31 | $142.00K 10-K · filed 2022-03-03 | $133.00K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |